RxDoctor Payments Data

Rick Visor, MD

Otolaryngology · Oklahoma City, OKNPI 1487611570

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Intersect ENT, Inc. at 34.9% of the total. 2025 is the largest year on record at $439, 2.0 times the $217 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in OK, where the typical reported total is $1,028.

$1,164in general payments, 2019–2025

Across 20 payments — averaging $58.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$406
  • Integra Lifesciences Corporation$324
  • Regeneron Healthcare Solutions, Inc.$240
  • Paratek Pharmaceuticals, Inc.$116
  • Stryker$36
  • Alk-abello, Inc$15
  • plus $27 from 2 others

What the payments were for

  • Travel & lodging$101%
  • Food & beverage$1,15499%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,164 in reported general payments places this provider in the 50th percentile of 109 otolaryngology providers in Oklahoma.

See all otolaryngology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$83,134
Medicare patients
367
Services billed
946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide71$1,858
Fluticasone Propionate55$1,525
Cefdinir40$832
Mupirocin86$824
Azithromycin94$773
Doxycycline Monohydrate30$723
Omeprazole20$487
Ofloxacin18$471
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$392
Methylprednisolone30$235
Doxycycline Hyclate18$222
Famotidine14$144
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$143
Dexamethasone17$104
Ciprofloxacin Hcl13$101

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →